Cas:886766-28-5 4,7-Diazaspiro[2.5]octane-7-carboxylic acid tert-butyl ester manufacturer & supplier

Chemical Name:4,7-Diazaspiro[2.5]octane-7-carboxylic acid tert-butyl ester

CAS.NO:886766-28-5

Synonyms:4,7-Diazaspiro[2.5]octane-7-carboxylic acid, 1,1-dimethylethyl ester;tert-Butyl-4,7-diazaspiro[2.5]octan-7-carboxylat;2-Methyl-2-propanyl 4,7-diazaspiro[2.5]octane-7-carboxylate;tert-butyl 4,7-diazaspiro[2.5]octane-7-carboxylate

Molecular Formula:C₁₁H₂₀N₂O₂

Molecular Weight:212.289

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:301.3±17.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.521

PSA:41.57000

Exact Mass:212.152481

LogP:0.94

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4,7-Diazaspiro[2.5]octane-7-carboxylic acid, 1,1-dimethylethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl 4,7-diazaspiro[2.5]octane-7-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-Butyl-4,7-diazaspiro[2.5]octan-7-carboxylat Use and application,2-Methyl-2-propanyl 4,7-diazaspiro[2.5]octane-7-carboxylate technical grade,usp/ep/jp grade.

Related News: Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. 4,7-Diazaspiro[2.5]octane-7-carboxylic acid tert-butyl ester manufacturer As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. 4,7-Diazaspiro[2.5]octane-7-carboxylic acid tert-butyl ester supplier Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. 4,7-Diazaspiro[2.5]octane-7-carboxylic acid tert-butyl ester vendor At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival. 4,7-Diazaspiro[2.5]octane-7-carboxylic acid tert-butyl ester factory At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.